REFERENCES
1. Whyte M.P. Hypophosphatasia: an overview for 2017. Bone. 2017; 102: 15–25.
2. Tournis S., et al. Hypophosphatasia. J Clin Med. 2021; 10 (23).
3. Fenn J.S., et al. Hypophosphatasia. J Clin Pathol. 2021; 74 (10): 635–40.
4. Mornet E., et al. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet. 2021; 29 (2): 289–99.
5. Villa-Suárez J.M., et al. Hypophosphatasia: a unique disorder of bone mineralization. Int J Mol Sci. 2021; 22 (9): 4303.
6. Salles J.P. Hypophosphatasia: biological and clinical aspects, avenues for therapy. Clin Biochem Rev. 2020; 41 (1): 13–27.
7. Mornet E. Hypophosphatasia. Metabolism. 2018; 82: 142–55.
8. Whyte M.P., et al. Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J Clin Endocrinol Metab. 2016; 101 (1): 334–42.
9. Narogan M.V., Ryumina I.I., Zubkov V.V.Perinatal and infantile forms of hypophosphatasia (etiopathogenesis, diagnosis, treatment options). Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2018; 7 (1): 38–46. (in Russian)
10. Khan A.A., et al. Hypophosphatasia: Canadian update on diagnosis and management. Osteoporos Int. 2019; 30 (9): 1713–22.
11. Bangura A., Wright L., Shuler T. Hypophosphatasia: current literature for pathophysiology, clinical manifestations, diagnosis, and treatment. Cureus. 2020; 12 (6): E8594.
12. Hofmann C.E., et al. Efficacy and safety of asfotase alfa in infants and young children with hypophosphatasia: a phase 2 open-label study. J Clin Endocrinol Metab. 2019; 104 (7): 2735–47.
13. Whyte M.P., et al. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 2019; 7 (2): 93–105.
14. Whyte M.P., et al. Natural history of perinatal and infantile hypophosphatasia: a retrospective study. J Pediatr. 2019; 209: 116–24.e4.
15. Chinoy A., et al. Normal mid-gestation fetal ultrasonography cannot reliably exclude severe perinatal hypophosphatasia. Horm Res Paediatr. 2021; 94 (7–8): 307–12.
16. Castells L., et al. Neonatal lethal hypophosphatasia. A case report and review of literature. Medicine (Baltimore). 2018; 97 (48): e13269.
17. Whyte M.P., et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med. 2012; 366 (10): 904–13.
18. Sperelakis-Beedham B., et al. Utility of genetic testing for prenatal presentations of hypophosphatasia. Mol Genet Metab. 2021; 132 (3): 198–203.